Vitamin D boosts levels, not symptomsSerum 25-hydroxyvitamin D levels in patients with atopic eczema and the influence of narrowband ultraviolet B phototherapy.
We examined how vitamin D3 levels affect atopic dermatitis, commonly known as eczema, particularly in patients undergoing narrowband ultraviolet B (nbUVB) therapy. This study involved 38 patients divided by gender and severity of their dermatitis, and tracked changes in both their vitamin D levels and their eczema severity before and after treatment.
Following the nbUVB therapy, we noted a remarkable increase in the median serum vitamin D levels—from 45 nmol/l before treatment to 169 nmol/l after treatment. Alongside this boost in vitamin D levels, we also observed a noteworthy reduction in eczema severity, with the average score dropping significantly.
However, our findings did not show a clear connection between the increase in vitamin D levels and the improvement in eczema severity. This suggests that while patients with eczema may benefit from increased vitamin D due to treatments like nbUVB, the direct relationship between vitamin D levels and eczema severity isn't confirmed by our study.
Overall, while patients with atopic dermatitis may be at risk of vitamin D deficiency, our results imply that simply increasing vitamin D levels might not guarantee improvements in eczema severity.
Read More
Vitamin D's role in eczema severityChanges and clinical significance of serum vitamin A, 25-(OH)D3, TG2, IL-4 and IL-13 levels in children with eczema.
We investigated the levels of vitamin D and other related factors in children suffering from eczema to better understand their relationship with the severity of this condition. Our analysis included 159 children, categorized by the severity of their eczema symptoms into mild, moderate, and severe groups.
Over the course of the study, we observed that as eczema severity increased, serum levels of vitamin A and 25-(OH)D3 (a form of vitamin D) tended to decrease. Conversely, levels of tissue transglutaminase (TG2), interleukin-4 (IL-4), and interleukin-13 (IL-13), which are markers of inflammation, increased. Significant correlations emerged showing that lower levels of vitamin A and 25-(OH)D3 were linked to higher SCORAD scores (a measure of eczema severity), while increases in TG2, IL-4, and IL-13 levels paralleled worsening symptoms.
Importantly, vitamin D levels had the highest accuracy for assessing eczema severity compared to the other markers studied. After treatment over three months, we noted improvements in the levels of all measured indicators, suggesting that addressing these serum factors could have a positive impact on managing eczema symptoms.
Our findings indicate that monitoring vitamin D levels, along with other serum indicators, might offer valuable insights for clinicians in evaluating and treating eczema in children.
Read More
Vitamin D reduces eczema severityVitamin D Supplementation for Treating Atopic Dermatitis in Children and Adults: A Systematic Review and Meta-Analysis.
We focused on understanding the impact of vitamin D supplementation on atopic dermatitis, commonly known as eczema, in both children and adults. This systematic review analyzed data from eleven randomized controlled trials (RCTs), involving a total of 686 participants.
Each study compared participants receiving vitamin D to those in control groups, measuring their eczema severity using established scoring systems. The results were compelling. We found that vitamin D supplementation led to a noteworthy reduction in eczema severity compared to those who did not receive this treatment.
Specifically, the analysis indicated a standardized mean difference of -0.41, suggesting significant benefits for individuals taking vitamin D. However, it’s essential to note that while the findings are promising, larger and longer-term studies are necessary to confirm these results.
Read More
Maternal vitamin D influences infant eczemaCorrelation of Maternal Vitamin D Status in Early Pregnancy and Vitamin D Supplementation during Pregnancy with Atopic Dermatitis in Infants: A Prospective Birth Cohort Study.
We examined the relationship between maternal vitamin D levels during early pregnancy and the occurrence of atopic dermatitis (AD), commonly known as eczema, in infants. Our study involved 4,051 woman-infant pairs, focusing on those with singleton pregnancies. We looked closely at the vitamin D levels of mothers in their first trimester and analyzed how these levels, along with vitamin D supplementation during pregnancy, influenced the likelihood of infants developing AD.
The results showed that infants born to mothers with low vitamin D levels faced a significantly higher risk of developing eczema. Specifically, mothers with vitamin D deficiency had a 77% increased risk of their infants developing AD. Interestingly, this heightened risk was mostly observed in naturally conceived pregnancies, while those conceived through assisted reproductive techniques didn't show the same association.
Additionally, we found that mothers who took vitamin D or multivitamin supplements during pregnancy had a lower risk of having infants with AD. This suggests that adequate vitamin D intake may play a protective role against eczema in infants. Our findings underscore the importance of monitoring vitamin D levels in expectant mothers, as doing so could help reduce the risk of eczema in their future children.
Read More
Vitamin D's unclear role in eczemaA systematic review and meta-analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report.
We explored the effectiveness of dietary interventions, particularly vitamin D, in treating eczema symptoms in children without food allergies. Our systematic review included several randomized controlled trials (RCTs) that assessed various treatments. Among these, vitamin D was analyzed alongside other therapies like probiotics and evening primrose oil.
The findings revealed an overall trend suggesting that probiotics, especially when combined with prebiotics, could lead to a notable reduction in eczema symptoms as measured by standard scoring systems. However, the evidence specifically highlighting vitamin D's role in alleviating eczema was limited. This indicates that while some dietary approaches show promise, the impact of vitamin D alone remains less clear.
Thus, we recognize the need for more focused research that can specifically examine the effects of vitamin D on eczema, ideally isolating it from other dietary factors. Well-structured studies are essential to deepen our understanding and develop effective treatment strategies for managing eczema in children.
Read More